Skip to main content
Clinical Trials/JPRN-UMIN000009990
JPRN-UMIN000009990
Completed
未知

Comparison of Clinical Effects of Salmeterol/Fluticasone Propionate Combination Products Delivered via Metered-Dose Inhaler with Dry Powder Inhaler in Patients with Moderate Asthma - SFC Diskus vs aerosol inhaler

ational Center for Global Health and Medicine0 sites40 target enrollmentFebruary 8, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Bronchial asthma
Sponsor
ational Center for Global Health and Medicine
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 8, 2013
End Date
July 27, 2013
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ational Center for Global Health and Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Current smokers, those who had pulmonary diseases with non reversible airflow obstruction such as COPD or pulmonary fibrosis were excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Assessments of the effect of Salmeterol and Fluticasone Propionate (SFC250) on the patients with chronic obstructive pulmonary disease by Impulse OscillometryChronic Obstructive Pulmonary Disease
JPRN-UMIN000004196St. Marianna University School of Medicine, Division of Respiratory and Infectious Diseases200
Completed
Phase 4
Study to examine the effects of Salmeterol/fluticasone propionate combination(SFC) in patients with cough variant asthma(CVA)
JPRN-UMIN000002390Kyoto University Graduate School of Medicine60
Active, not recruiting
Not Applicable
Efficacy and safety of Salmeterol/Fluticasone DPI HEXAL versus Seretide™ Accuhaler™ in adolescent and adult patients with moderate-to-severe persistent asthma: A 12-week, multicenter, randomized, double-blind, double-dummy, parallel group study
EUCTR2007-005620-32-LTHEXAL AG472
Active, not recruiting
Phase 1
Efficacy and safety of Salmeterol/Fluticasone DPI HEXAL versus Seretide™ Accuhaler™ in adolescent and adult patients with moderate-to-severe persistent asthma: A 12-week, multicenter, randomized, double-blind, double-dummy, parallel group study
EUCTR2007-005620-32-PLHEXAL AG472
Active, not recruiting
Not Applicable
Efficacy and safety of Salmeterol/Fluticasone DPI HEXAL versus Seretide™ Accuhaler™ in adolescent and adult patients with moderate-to-severe persistent asthma: A 12-week, multicenter, randomized, double-blind, double-dummy, parallel group studymoderate-to-severe persistent asthmaMedDRA version: 9.1Level: LLTClassification code 10003555Term: Asthma bronchial
EUCTR2007-005620-32-HUHEXAL AG472